Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mary Linton Bounetheau Peters"'
Publikováno v:
Journal of Clinical Oncology. 41:516-516
516 Background: Combined hepatocellular intrahepatic cholangiocarcinoma (HCC CC) is a rare tumor defined by pathologic characteristics of both hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). Immunohistochemical (IHC) and gen
Autor:
Zachary M Avigan, Rodrigo Paredes, Leora S Boussi, Barbara Lam, Meghan Shea, Matthew Weinstock, Mary Linton Bounetheau Peters
Publikováno v:
Journal of Clinical Oncology. 40:42-42
42 Background: COVID-19 presents a particular challenge in oncology, as in-person visits and treatments can be delayed during infection and patients are at risk for prolonged viral shedding. Our center uses two consecutive negative PCR tests for pati
Uptake in genetic testing in patients with pancreatic cancer with oncologist-driven testing protocol
Autor:
Traci King, Page Widick, Rodrigo Paredes, Oliver Klein, Jill Krejdovsky, Nadine M. Tung, Mary Linton Bounetheau Peters
Publikováno v:
Journal of Clinical Oncology. 40:33-33
33 Background: The objective was to compare the uptake of genetic testing in patients with pancreatic adenocarcinoma (PDAC) seen at a single center (1) before the 2019 NCCN recommendation of universal screening for genetic mutations in all new PDAC d
Autor:
Mary Linton Bounetheau Peters, Barak Davidi, Claudia L. Seguin, Andrew Eckel, Pari Pandharipande
Publikováno v:
Journal of Clinical Oncology. 40:10513-10513
10513 Background: Universal germline genetic testing is recommended for all patients with pancreatic ductal adenocarcinoma (PDAC). In addition to treatment implications for the patient, it is valuable for family members of the PDAC patient to underta